TRIAL WATCH Phase III promise for oral multiple sclerosis therapy

被引：0
|
作者：
不详
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 02期
关键词：
D O I：
10.1038/nrd2821
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [31] Phase I trial shows promise for re-educating the immune system of multiple sclerosis patients
    Patience, Jonny
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (07) : 597 - 597
  • [32] STEM-CELL THERAPY SHOWS PROMISE FOR MULTIPLE SCLEROSIS
    不详
    NATURE, 2023, 613 (7944) : 416 - 416
  • [33] Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial
    Olsson, Tomas
    Boster, Aaron
    Fernandez, Oscar
    Freedman, Mark S.
    Pozzilli, Carlo
    Bach, Doris
    Berkani, Ouali
    Mueller, Markus S.
    Sidorenko, Tatiana
    Radue, Ernst-Wilhelm
    Melanson, Maria
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (11): : 1198 - 1208
  • [34] Teriflunomide shows promise for MS treatment in phase III trial
    Heather Wood
    Nature Reviews Neurology, 2011, 7 (12) : 657 - 657
  • [35] Novel antiarrhythmic agent shows promise in Phase III trial
    Nature Reviews Drug Discovery, 2009, 8 : 266 - 266
  • [36] Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis
    Miller, Aaron E.
    O'Connor, Paul
    Wolinsky, Jerry S.
    Confavreux, Christian
    Kappos, Ludwig
    Olsson, Tomas P.
    Truffinet, Philippe
    Wang, Lin
    D'Castro, Laura
    Comi, Giancarlo
    Freedman, Mark S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) : 1625 - 1632
  • [37] Novel antiarrhythmic agent shows promise in Phase III trial
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (04) : 266 - 266
  • [38] A new oral Agent for the Therapy of multiple Sclerosis
    Borchers, Anja
    NERVENHEILKUNDE, 2011, 30 (12) : 1019 - 1019
  • [39] Oral laquinimod therapy in relapsing multiple sclerosis
    Preiningerova, Jana
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (07) : 985 - 989
  • [40] Oral TB vaccine shows promise in Phase 2 trial
    Riedmann, Eva M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (07) : 850 - 850
12345